SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-12-001802
Filing Date
2012-05-10
Accepted
2012-05-10 08:01:17
Documents
3
Period of Report
2012-06-15
Effectiveness Date
2012-05-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_051012.htm DEF 14A 469394
2 holliman.gif GRAPHIC 3021
3 logo.gif GRAPHIC 6537
  Complete submission text file 0001171843-12-001802.txt   483948
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33560 | Film No.: 12827774
SIC: 2834 Pharmaceutical Preparations